UNASSIGNED:急性重度有机磷农药中毒(ASOPP)是危害人类生命健康的重大疾病之一。然而,包括胃灌洗在内的常规治疗的效果,机械通气,毒蕈碱拮抗剂药物,和胆碱酯酶再激活剂不确定。本荟萃分析旨在探讨血液灌流联合血液滤过治疗ASOPP的安全性和有效性。
UNASSIGNED:通过PubMed对候选出版物进行了全面搜索,Medline,科克伦图书馆,万方,中国生物医学文献,和中国国家知识基础设施从数据库开始到2020年5月12日。根据预定义的纳入和排除标准对检索到的研究进行筛选。提取重要终点数据。对分类变量和连续变量进行风险比(RR)和加权平均差(WMD)汇总,分别。使用STATA软件15.1版进行Meta分析和发表偏倚。
UNASSIGNED:共纳入11项随机对照试验,包含811例患者。与常规治疗组相比,血液灌流加血液滤过组患者的死亡率明显优于对照组(RR0.38,95%置信区间[CI][0.25,0.57],P<0.001),阿托品总剂量(WMD-147.34mg,95%CI[-199.49,-95.18],P<0.001),机械通气的持续时间(WMD-2.34天,95%CI[-3.77,-0.92],P<0.001),胆碱酯酶恢复时间(WMD-2.49天,95%CI[-3.14,-1.83],P<0.001),和停留时间(大规模杀伤性武器-4.52天,95%CI[-5.31,-3.73],P<0.001)。
UASSIGNED:联合血液灌流和血液滤过是一种非常安全有效的ASOPP治疗方案,不仅导致死亡率显着降低,而且导致总阿托品剂量减少,机械通气的持续时间,胆碱酯酶恢复时间,和逗留时间的长短。
UNASSIGNED: Acute severe organophosphorus pesticide poisoning (ASOPP) is one of the major diseases that endanger human life and health. However, the effects of conventional therapy including gastric lavages, mechanical ventilation, muscarinic antagonist drugs, and cholinesterase reactivators were uncertain. This meta-analysis aims to investigate the safety and efficacy of hemoperfusion combined with hemofiltration besides routine therapy for ASOPP.
UNASSIGNED: A comprehensive search for candidate publications was performed through PubMed, Medline, Cochrane Library, WanFang, Chinese Biomedical Literature, and China National Knowledge Infrastructure from database inception to May 12, 2020. The retrieved studies were screened by the predefined inclusion and exclusion criteria. The data of important end points were extracted. The risk ratio (RR) and weighted mean difference (WMD) were pooled for categorical variables and continuous variables, respectively. Meta-analyses and publication bias were conducted by using STATA software version 15.1.
UNASSIGNED: A total of 11 randomized controlled trials with 811 patients were included. Compared to conventional therapy group, patients in the hemoperfusion plus hemofiltration group were significantly superior with regard to mortality (RR 0.38, 95% confidence interval [CI] [0.25, 0.57], P < 0.001), total atropine dosing (WMD -147.34 mg, 95% CI [-199.49, -95.18], P < 0.001), duration of mechanical ventilation (WMD -2.34 days, 95% CI [-3.77, -0.92], P < 0.001), cholinesterase recovery time (WMD -2.49 days, 95% CI [-3.14, -1.83], P < 0.001), and length of stay (WMD -4.52 days, 95% CI [-5.31, -3.73], P < 0.001).
UNASSIGNED: Combined hemoperfusion and hemofiltration was a very safe and effective treatment protocol for ASOPP, not only resulting in significantly decreased mortality but also resulting in reduced total atropine dosing, duration of mechanical ventilation, cholinesterase recovery time, and length of stay.